跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,153 条关于
“Nerivio REN”
全部
5,153
临床试验
4,174
药物
554
机构
110
资讯
315
去年
FDA Expands Nerivio REN Wearable Approval for Migraine Treatment in Children Aged 8+
去年
Theranica's Nerivio REN Wearable Shows Sustained Migraine Efficacy Over Three Years in Real-World Studies
11个月前
Theranica Presents Real-World Evidence Supporting Drug-Free Migraine Treatment at CNS 2025
9个月前
Major Mid-Atlantic Insurer Expands Coverage for Nerivio Migraine Device, Providing Access to 3.4 Million Members
10个月前
Nerivio Wearable Device Shows No Tachyphylaxis in 3-Year Migraine Study
11个月前
China Approves First REN-Based Migraine Wearable Device, Opening New Treatment Pathway for 130 Million Patients
去年
FDA Approves Nerivio for Acute Migraine Treatment in Pediatric Patients Aged 8+
去年
FDA Approves AI Tool for ARIA Detection, Expands Nerivio Indication, and Grants Accelerated Approval to Gene Therapy for AADC Deficiency
去年
FDA Approves Nerivio for Migraine Treatment in Children Aged 8 and Older
去年
Migraine Treatment Advances: CGRP Inhibitors, Digital Therapeutics, and Novel Compounds Highlight 2024
第 1 页,共 32 页
上一页
下一页